Serotonin, Impulsivity, and Cocaine Dependence Treatment
The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Serotonin, Impulsivity, and Cocaine Dependence Treatment|
- The presence of cocaine metabolites in urine weekly.
- Retention rate and cocaine cravings weekly.
|Study Start Date:||April 2001|
|Estimated Study Completion Date:||November 2004|
Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopram for cocaine dependence. The primary outcome measure is benzoylecgonine positive urines. Secondary measures of side effects and craving are also examined.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00297505
|United States, Texas|
|University of Texas – Houston Health Science Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Frederick G Moeller, M.D.||The University of Texas Health Science Center, Houston|